E-LIB Suche - Ergebnisse für: Ganshina, I.

1

Efficacy of eribulin in patients with metastatic breast can..:

Kolyadina, I. ; Bulavina, I. ; Petkau, V....
The Breast. 44 (2019) - p. S62 , 2019

Link: https://doi.org/10.1016/..

2

The first results of neoadjuvant therapy with the biosimila..:

Kolyadina, I. ; Ganshina, I. ; Zhukova, L....
European Journal of Cancer. 92 (2018) - p. S107-S108 , 2018

Link: https://doi.org/10.1016/..

3

P26 HER-2 overexpressed breast cancer and brain metastases:

Lichinitse, M. ; Ganshina, I. ; Zhukova, L...
The Breast. 16 (2007) - p. S19 , 2007

Link: https://doi.org/10.1016/..

4

Ribociclib in 1st line HR+ breast cancer treatment:

Zhukova, L G ; Ganshina, I P ; Gordeeva, O O.
Journal of Modern Oncology. 20 (2018) 2 - p. 38-41 , 2018

Link: https://doi.org/10.26442..

5

Optimal duration of adjuvant trastuzumab therapy in patient..:

Zhukova, L G ; Ganshina, I P ; Khatkova, E I..
Journal of Modern Oncology. 20 (2018) 2 - p. 24-28 , 2018

Link: https://doi.org/10.26442..

6

Serous cavities of coelomic origin as possible organs of th..:

Ganshina, I. V.
Biology Bulletin Reviews. 7 (2017) 2 - p. 129-138 , 2017

Link: https://doi.org/10.1134/..

7

Serous cavities of coelomic origin as possible organs of th..:

Ganshina, I. V.
Biology Bulletin Reviews. 6 (2016) 6 - p. 497-504 , 2016

Link: https://doi.org/10.1134/..

8

PHOSPHORILATED POLYPRENOLS — A NOVEL CLASS OF COMPOUNDS WIT..:

Sanin, A. V. ; Ganshina, I. V. ; Sudiyna, G. F....
Russian Journal of Infection and Immunity. 1 (2014) 4 - p. 355-360 , 2014

Link: https://doi.org/10.15789..

9

120 High pathological complete response rate of neo-adjuvan..:

Zeynalova, K.R. ; Vishnevskaya, Y.V. ; Ganshina, I.P.
European Journal of Cancer Supplements. 8 (2010) 3 - p. 93-94 , 2010

Link: https://doi.org/10.1016/..

10

Variations in the number of regulatory T cells (CD4+CD25+) ..:

Slavina, E. G. ; Chertkova, A. I. ; Zabotina, T. N...
Bulletin of Experimental Biology and Medicine. 141 (2006) 3 - p. 361-363 , 2006

Link: https://doi.org/10.1007/..

11

Optimal duration of adjuvant trastuzumab therapy in patient..:

Zhukova L.G ; Ganshina I.P ; Khatkova E.I..
https://doi.org/10.26442/1815-1434_2018.2.24-28. , 2020

Link: https://openrepository.r..

12

PHOSPHORILATED POLYPRENOLS — A NOVEL CLASS OF COMPOUNDS WIT..:

Sanin A.V ; Ganshina I.V ; Sudiyna G.F...
https://iimmun.ru/iimm/article/view/69/68. , 2014

Link: https://iimmun.ru/iimm/a..

13

CHARACTERISTICS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN ..:

D. Morozov A ; I. Kolyadina V ; I. Ganshina P...
https://www.malignanttumors.org/jour/article/view/924/667. , 2022

Link: https://www.malignanttum..

14

Russian multicenter experience of using talazoparib in the ..:

T. Semiglazova Yu ; E. Lubennikova V ; L. Bolotina V...
https://www.med-sovet.pro/jour/article/view/5937/5420. , 2020

Link: https://www.med-sovet.pr..

15

ASSOCIATION OF NKT- AND ACTIVATED CD25+ PERIPHERAL BLOOD LY..:

A. Chertkova I ; E. Slavina G ; T. Zabotina N...
https://www.siboncoj.ru/jour/article/view/1641/809. , 2020

Link: https://www.siboncoj.ru/..